AstraZeneca – Working collaboratively to support you in “setting the scene” to offering
“High Quality Care for all”.
AstraZeneca is committed to improving patient care and would like to share how we have already made this happen within respiratory medicine. We would like to give you insight into how we are supporting a changing NHS to achieve many of the WCC competencies and meet the QIPP agenda. With the National COPD strategy imminent, we would also like to showcase examples that meet the aspirations of this strategy and share the outcomes with you.
AstraZeneca has designed an interactive and engaging session that will enable workshop attendees to have a clear understanding of AZ tools and how they support many of the recommendations in the COPD Strategy. Delegates will be able to hear about a real life example (AIRWAYS), and understand how AstraZeneca’s tools and clinical service team facilitated change in the NHS to improve patient care, clinical outcomes and reduced expenditure within the NHS.


"The Boehringer-Ingelheim workshop will demonstrate examples of “peer-led” medical education programmes which are designed to be used in convenient and flexible settings.
These educational programmes are intended to improve accurate diagnosis and management of COPD patients. By enhancing knowledge, expertise and confidence among Health Care Professionals, benefits to patients on-going care and long-term outcomes may be seen."


GlaxoSmithKline- Working in partnership to improve quality and efficiency of COPD care.
Our workshop will focus on how our service offering and experience can contribute to the implementation of the first phase of Clinical Strategy for COPD and the quality and productivity challenge through working in partnership with the NHS to pool complementary skills and resources. The workshop will cover:
• Our approach to driving sustainable improvement in the management of COPD using the set of tools within our service offering
• How we can support the implementation of eight of the recommendations set out in the Strategy • • Evidence from previous work we have done with the NHS that demonstrates how we have played a role in improving patient outcomes in a cost-effective way by reducing admissions
• Overview of how we intend to work with interested organisations to ensure transparency and shared objectives for both parties in line with the ABPI joint working framework


Pfizer Workshop
NHS partners have helped us build a session to provide:
• Insight into the value of our resources
•Worked examples of the challenges and successes of delivering specific aspects of the strategy
• An NHS perspective of working in partnership
We look forward to working with you.


Aim of the Quintiles workshop:
The NHS is charged with increasing Quality whilst reducing its patient spends and without compromise to patient safety.
Quintiles will describe and discuss the provision of a robust model of integrated disease management (IDM) that befits the NHS agenda of quality and service improvement, the core elements of which are:
· Bring patient benefits in terms of COPD functional status
· Reduce the cost burden of disease processes identified within the management of patients with COPD (delivery on the QIPP agenda)
· How it relates to the implementation of the National Strategy for COPD, appropriate management guidelines (e.g. NICE) and alignment to the needs of your local population
· Compatibility with the operational activities of a PCT commissioner, provider and Practice Based Commissioning Group